Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 17.07
(1.01%)
CNY 17.07
(1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.13 Billion | 1.14 Billion | 1.09 Billion | 1.14 Billion | 1.61 Billion | 1.5 Billion |
| Cost of Revenue | 495.62 Million | 486.28 Million | 454.48 Million | 439.5 Million | 447.75 Million | 427.12 Million |
| Gross Profit | 634.54 Million | 660.3 Million | 637.45 Million | 701.33 Million | 1.16 Billion | 1.07 Billion |
| Operating Expenses | 265.07 Million | 576.84 Million | 591.84 Million | 643.25 Million | 971.52 Million | 903.13 Million |
| Selling, General and Administrative Expenses | 297.46 Million | 362.48 Million | 391.65 Million | 453.41 Million | 726.39 Million | 688.77 Million |
| Research and Development Expenses | 105.84 Million | 105.97 Million | 104.08 Million | 76.69 Million | 123.42 Million | 94.29 Million |
| Other Expenses | -289.92 Million | 108.38 Million | 96.11 Million | 113.14 Million | 121.7 Million | -1.02 Million |
| Cost and Expenses | 733.22 Million | 1.06 Billion | 1.04 Billion | 1.08 Billion | 1.41 Billion | 1.33 Billion |
| Operating Income | 419.8 Million | 175.67 Million | 136.9 Million | 102.35 Million | 220.14 Million | 215.01 Million |
| Interest Expense | 876.4 Thousand | 875.18 Thousand | 320.49 Thousand | 529.91 Thousand | 1.35 Million | 2.65 Million |
| Income Tax Expense | 58.38 Million | 24.75 Million | 15.01 Million | 22.31 Million | 28.65 Million | 29.01 Million |
| Earnings before Tax | 420.21 Million | 118.36 Million | 137.12 Million | 30.93 Million | 216.79 Million | 213.98 Million |
| Net Income | 361.82 Million | 93.6 Million | 122.1 Million | 8.61 Million | 188.13 Million | 184.97 Million |
| Earnings Per Share Basic | 1.97 | 0.51 | 0.67 | 0.05 | 1.03 | 1.01 |
| Earnings Per Share Diluted | 1.97 | 0.51 | 0.67 | 0.05 | 1.03 | 1.01 |
| Weighted Average Shares Outstanding | 183.66 Million | 182.45 Million | 182.45 Million | 182.45 Million | 182.45 Million | 182.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 183.66 Million | 182.45 Million | 182.45 Million | 182.45 Million | 182.45 Million | 183.14 Million |
| Gross Margin | 0.56 | 0.58 | 0.58 | 0.61 | 0.72 | 0.72 |
| EBIT Margin | 0.42 | 0.21 | 0.19 | 0.15 | 0.19 | 0.19 |
| Profit Margin | 0.32 | 0.08 | 0.11 | 0.01 | 0.12 | 0.12 |
| EBITDA | 477.37 Million | 175.15 Million | 197.64 Million | 83.6 Million | 272.16 Million | 271.43 Million |
| Earnings Before Tax Margin | 0.37 | 0.15 | 0.13 | 0.09 | 0.14 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 274.15 Million | 373.03 Million | 358.78 Million | 1.13 Billion | 235.85 Million | 254.07 Million |
| Cost of Revenue | 132.05 Million | 160.91 Million | 172.14 Million | 495.62 Million | 122.1 Million | 103.23 Million |
| Gross Profit | 142.09 Million | 212.12 Million | 186.64 Million | 634.54 Million | 113.74 Million | 150.84 Million |
| Operating Expenses | 139.62 Million | 172.98 Million | 148.52 Million | 521.91 Million | 130.45 Million | 111.77 Million |
| Selling, General and Administrative Expenses | 100.22 Million | 145.42 Million | 123.94 Million | - | 75.99 Million | 132.92 Million |
| Research and Development Expenses | 39.17 Million | 27.56 Million | 24.58 Million | - | 25.21 Million | 11.94 Million |
| Other Expenses | -228.11 Thousand | -225.66 Thousand | 112.84 Thousand | -13.83 Million | -29.25 Million | 149.44 Thousand |
| Cost and Expenses | 271.67 Million | 333.89 Million | 320.67 Million | 1.01 Billion | 252.56 Million | 215 Million |
| Operating Income | 2.47 Million | 39.14 Million | 38.11 Million | 112.62 Million | -16.71 Million | 298.78 Million |
| Interest Expense | - | 802.95 Thousand | 922.01 Thousand | 876.4 Thousand | 255.25 Thousand | 115.64 Thousand |
| Income Tax Expense | 14.33 Million | 10.45 Million | 8.9 Million | 58.38 Million | -3.91 Million | 46.45 Million |
| Earnings before Tax | 11.15 Million | 62.33 Million | 58.3 Million | 409.19 Million | 12.88 Million | 298.93 Million |
| Net Income | 66.89 Million | 43.19 Million | 59.15 Million | 361.82 Million | 19.16 Million | 252.48 Million |
| Earnings Per Share Basic | 0.26 | 0.17 | 0.32 | - | 0.10 | 1.38 |
| Earnings Per Share Diluted | 0.26 | 0.17 | 0.32 | - | 0.10 | 1.38 |
| Weighted Average Shares Outstanding | 255.43 Million | 255.43 Million | 182.42 Million | 183.66 Million | 186.09 Million | 182.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 255.43 Million | 255.43 Million | 182.42 Million | 183.66 Million | 186.09 Million | 182.45 Million |
| Gross Margin | 0.52 | 0.57 | 0.52 | 0.56 | 0.48 | 0.59 |
| EBIT Margin | 0.04 | 0.16 | 0.18 | - | -0.00 | 0.24 |
| Profit Margin | 0.24 | 0.12 | 0.16 | 0.32 | 0.08 | 0.99 |
| EBITDA | 11.15 Million | 58.92 Million | 65.68 Million | - | -76.46 Thousand | 60.31 Million |
| Earnings Before Tax Margin | 0.01 | 0.10 | 0.11 | 0.10 | -0.07 | 1.18 |
CRZBY
MRC
6MK
2345
YCP
TAM